Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
McKinsey
Dow
Harvard Business School
Boehringer Ingelheim

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR LABETALOL HYDROCHLORIDE IN DEXTROSE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Labetalol Hydrochloride In Dextrose

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000291 ↗ Effects of Labetalol on Human Cocaine Use - 8 Completed University of Minnesota Phase 2 1997-10-01 The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
NCT00000291 ↗ Effects of Labetalol on Human Cocaine Use - 8 Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 1997-10-01 The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
NCT00000291 ↗ Effects of Labetalol on Human Cocaine Use - 8 Completed National Institute on Drug Abuse (NIDA) Phase 2 1997-10-01 The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
NCT00000297 ↗ Effects of Labetalol on Nicotine Administration in Humans - 14 Completed University of Minnesota Phase 2 1998-10-01 The purpose of this study is to investigate the effects of labetalol in response to intravenous nicotine
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Labetalol Hydrochloride In Dextrose

Condition Name

Condition Name for Labetalol Hydrochloride In Dextrose
Intervention Trials
Hypertension in Pregnancy 7
Preeclampsia 6
Hypertension 6
Hypertension, Pregnancy-Induced 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Labetalol Hydrochloride In Dextrose
Intervention Trials
Pre-Eclampsia 21
Hypertension 21
Hypertension, Pregnancy-Induced 15
Eclampsia 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Labetalol Hydrochloride In Dextrose

Trials by Country

Trials by Country for Labetalol Hydrochloride In Dextrose
Location Trials
United States 38
Egypt 9
Canada 7
Saudi Arabia 2
India 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Labetalol Hydrochloride In Dextrose
Location Trials
New York 11
Ohio 4
California 4
Texas 3
Tennessee 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Labetalol Hydrochloride In Dextrose

Clinical Trial Phase

Clinical Trial Phase for Labetalol Hydrochloride In Dextrose
Clinical Trial Phase Trials
Phase 4 22
Phase 3 6
Phase 2/Phase 3 2
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Labetalol Hydrochloride In Dextrose
Clinical Trial Phase Trials
Completed 28
Recruiting 10
Unknown status 8
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Labetalol Hydrochloride In Dextrose

Sponsor Name

Sponsor Name for Labetalol Hydrochloride In Dextrose
Sponsor Trials
Weill Medical College of Cornell University 3
University of Alberta 3
Mansoura University 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Labetalol Hydrochloride In Dextrose
Sponsor Trials
Other 77
NIH 4
U.S. Fed 4
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
McKinsey
Dow
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.